Why healing becomes harder on GLP-1s Several factors contribute to healing challenges while taking Ozempic or similar medications: Reduced caloric intake: GLP-1 agonists dramatically decrease appetite
Celecoxib-induced gastrointestinal, liver and brain lesions in rats, counteraction by bpc 157 or l-arginine, aggravation by l-name
Starting at 250-300mcg regardless of body weight, then adjusting based on response, often works better than jumping to weight-based higher doses
For skin-specific research, topical delivery has four practical advantages that shape research protocol design
Needle selection matters If you are drawing from a vial, you have control over needle selection
Published on November 8th, 2025